Results for tag: "Myostatin Inhibitor"

The Myostatin Inhibitor market is a subset of the Musculoskeletal Disorders Drugs market. Myostatin Inhibitors are drugs that block the action of myostatin, a protein that limits muscle growth. These drugs are used to treat muscle wasting diseases, such as muscular dystrophy, as well as to improve muscle strength and endurance in healthy individuals. Myostatin Inhibitors are also being studied for their potential to treat age-related muscle loss and other conditions. Myostatin Inhibitors are still in the early stages of development, and there are currently no approved drugs on the market. However, several companies are researching and developing Myostatin Inhibitors, including Akashi Therapeutics, Cytokinetics, and Pfizer. Additionally, several biotechnology companies are developing gene therapies that target myostatin, such as Solid Biosciences and Sarepta Therapeutics. Show Less Read more